Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03707574 · ClinicalTrials.gov registry record

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
64
Enrollment target

NCT03707574: Completed study, sponsored by National Cancer Institute (NCI).

NCT03707574 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03707574 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
64 participants
Enrollment target

Study Summary

This trial studies the genetic analysis of blood and tissue samples from patients with cancer that has spread to other anatomic sites (advanced) or is no longer responding to treatment. Studying these samples in the laboratory may help doctors to learn how genes affect cancer and how they affect a person's response to treatment.

Interventions

  • PROCEDURE Biospecimen Collection

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2019-07-16
Est. Completion 2026-01-23

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT03707574

The ClinicalTrials.gov registry entry for NCT03707574 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Biospecimen Collection is the first listed.

NCT03707574 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03707574 about?

NCT03707574 is a clinical study titled "Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study". This trial studies the genetic analysis of blood and tissue samples from patients with cancer that has spread to other anatomic sites (advanced) or is no longer responding to treatment. Studying these samples in the laboratory may help doctors to learn how genes affect cancer and how they affect a p...

What is the current status of trial NCT03707574?

This trial is currently completed. The enrollment target is 64 participants. The study started on 2019-07-16. Estimated completion is 2026-01-23.

What interventions are being tested in trial NCT03707574?

The interventions under investigation include: Biospecimen Collection (PROCEDURE).

Who is sponsoring clinical trial NCT03707574?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.